EDITORIAL
Published on 08 May 2020
Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
doi 10.3389/fphar.2020.00660
- 1,643 views
- 2 citations
- Frontiers in Pharmacology
- Respiratory Pharmacology
- Research Topics
- Drug Development and Target Discovery in Pulmonary Vascular Diseases
Drug Development and Target Discovery in Pulmonary Vascular Diseases
5,707
Total downloads
19k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 26 Feb 2019
Activation of Nicotinic Acetylcholine α7 Receptor Attenuates Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Downregulating the NLRP3 Inflammasome
doi 10.3389/fphar.2019.00128
- 4,039 views
- 37 citations
ORIGINAL RESEARCH
Published on 22 Jan 2019
Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
doi 10.3389/fphar.2019.00013
- 2,693 views
- 23 citations
ORIGINAL RESEARCH
Published on 21 Jan 2019
Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
doi 10.3389/fphar.2018.01550
- 3,695 views
- 11 citations
ORIGINAL RESEARCH
Published on 18 Jan 2019
Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K+ Channels
doi 10.3389/fphar.2018.01518
- 4,085 views
- 11 citations
Published in
Frontiers in Pharmacology
- Respiratory Pharmacology
Impact
- 19kTopic views
- 12kArticle views
- 5,707Article downloads